^“PAR2 induces ovarian cancer cell motility by merging three signalling pathways to transactivate EGFR”. British Journal of Pharmacology178 (4): 913–932. (November 2020). doi:10.1111/bph.15332. PMID (33226635).
^“Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis”. Yonsei Medical Journal51 (6): 808–22. (November 2010). doi:10.3349/ymj.2010.51.6.808. PMC 2995962. PMID (20879045). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995962/.
^“Proteinase-activated receptor-2 in the skin: receptor expression, activation and function during health and disease”. Drug News & Perspectives21 (7): 369–81. (September 2008). doi:10.1358/dnp.2008.21.7.1255294. PMID (19259550).
^“Entrez Gene: F2RL1 coagulation factor II (thrombin) receptor-like 1”. 2021年4月29日閲覧。
^“Protease-activated receptors and their biological role - focused on skin inflammation”. The Journal of Pharmacy and Pharmacology67 (12): 1623–33. (December 2015). doi:10.1111/jphp.12447. PMID (26709036).
^“Potent and metabolically stable agonists for protease-activated receptor-2: evaluation of activity in multiple assay systems in vitro and in vivo”. The Journal of Pharmacology and Experimental Therapeutics309 (3): 1098–107. (June 2004). doi:10.1124/jpet.103.061010. PMID (14976227).
^“Thrombin-Mediated Direct Activation of Proteinase-Activated Receptor-2: Another Target for Thrombin Signaling”. Molecular Pharmacology89 (5): 606–14. (May 2016). doi:10.1124/mol.115.102723. PMID (26957205).
^“Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2”. American Journal of Physiology. Lung Cellular and Molecular Physiology278 (1): L193-201. (January 2000). doi:10.1152/ajplung.2000.278.1.l193. PMID (10645907).
^“Kallikrein protease activated receptor (PAR) axis: an attractive target for drug development”. Journal of Medicinal Chemistry55 (15): 6669–86. (August 2012). doi:10.1021/jm300407t. PMID (22607152).
^“Macrophage TLR4 and PAR2 Signaling: Role in Regulating Vascular Inflammatory Injury and Repair” (英語). Frontiers in Immunology11: 2091. (2020). doi:10.3389/fimmu.2020.02091. PMC 7530636. PMID (33072072). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530636/.
^“PAR2 induces ovarian cancer cell motility by merging three signalling pathways to transactivate EGFR”. British Journal of Pharmacology178 (4): 913–932. (November 2020). doi:10.1111/bph.15332. PMID (33226635).
^“Protease-activated receptors and their biological role - focused on skin inflammation”. The Journal of Pharmacy and Pharmacology67 (12): 1623–33. (December 2015). doi:10.1111/jphp.12447. PMID (26709036).
^“Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2”. American Journal of Physiology. Lung Cellular and Molecular Physiology278 (1): L193-201. (January 2000). doi:10.1152/ajplung.2000.278.1.l193. PMID (10645907).
^“Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells”. Journal of Immunology168 (7): 3577–85. (April 2002). doi:10.4049/jimmunol.168.7.3577. PMID (11907122).
^“Protease-activated receptors (PARs) in cancer: Novel biased signaling and targets for therapy”. Methods in Cell Biology132: 341–58. (2016). doi:10.1016/bs.mcb.2015.11.006. PMID (26928551).
^“Identification and characterization of novel small-molecule protease-activated receptor 2 agonists”. The Journal of Pharmacology and Experimental Therapeutics327 (3): 799–808. (December 2008). doi:10.1124/jpet.108.142570. PMID (18768780).
^“Novel agonists and antagonists for human protease activated receptor 2”. Journal of Medicinal Chemistry53 (20): 7428–40. (October 2010). doi:10.1021/jm100984y. PMID (20873792).
^“Structural insight into allosteric modulation of protease-activated receptor 2”. Nature545 (7652): 112–115. (May 2017). Bibcode: 2017Natur.545..112C. doi:10.1038/nature22309. PMID (28445455).
^“Structural Characterization of Agonist Binding to Protease-Activated Receptor 2 through Mutagenesis and Computational Modeling”. ACS Pharmacology & Translational Science1 (2): 119–133. (November 2018). doi:10.1021/acsptsci.8b00019. PMC 7088944. PMID (32219208). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088944/.
関連文献
“Ion transport induced by proteinase-activated receptors (PAR2) in colon and airways”. Cell Biochemistry and Biophysics36 (2–3): 209–14. (2003). doi:10.1385/CBB:36:2-3:209. PMID (12139406).
“PAR-2: structure, function and relevance to human diseases of the gastric mucosa”. Expert Reviews in Molecular Medicine4 (16): 1–17. (July 2002). doi:10.1017/S1462399402004799. PMID (14585156).
“The emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disorders”. The Journal of Physiology581 (Pt 1): 7–16. (May 2007). doi:10.1113/jphysiol.2007.129577. PMC 2075212. PMID (17347265). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075212/.
“Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2”. European Journal of Biochemistry232 (1): 84–9. (August 1995). doi:10.1111/j.1432-1033.1995.tb20784.x. PMID (7556175).
“Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes”. Proceedings of the National Academy of Sciences of the United States of America92 (20): 9151–5. (September 1995). Bibcode: 1995PNAS...92.9151S. doi:10.1073/pnas.92.20.9151. PMC 40942. PMID (7568091). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC40942/.
“Molecular cloning of a potential proteinase activated receptor”. Proceedings of the National Academy of Sciences of the United States of America91 (20): 9208–12. (September 1994). Bibcode: 1994PNAS...91.9208N. doi:10.1073/pnas.91.20.9208. PMC 44781. PMID (7937743). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC44781/.
“The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells”. The Journal of Clinical Investigation97 (7): 1705–14. (April 1996). doi:10.1172/JCI118597. PMC 507235. PMID (8601636). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC507235/.
“Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2”. The Biochemical Journal314 ( Pt 3) (3): 1009–16. (March 1996). doi:10.1042/bj3141009. PMC 1217107. PMID (8615752). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1217107/.
“Mechanisms of desensitization and resensitization of proteinase-activated receptor-2”. The Journal of Biological Chemistry271 (36): 22003–16. (September 1996). doi:10.1074/jbc.271.36.22003. PMID (8703006).
“Conserved structure and adjacent location of the thrombin receptor and protease-activated receptor 2 genes define a protease-activated receptor gene cluster”. Molecular Medicine2 (3): 349–57. (May 1996). doi:10.1007/BF03401632. PMC 2230143. PMID (8784787). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2230143/.
“Interactions of mast cell tryptase with thrombin receptors and PAR-2”. The Journal of Biological Chemistry272 (7): 4043–9. (February 1997). doi:10.1074/jbc.272.7.4043. PMID (9020112).
“Proteinase-activated receptor-2: expression by human neutrophils”. Journal of Cell Science110 ( Pt 7) (7): 881–7. (April 1997). PMID (9133675).
“Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues”. The Journal of Histochemistry and Cytochemistry46 (2): 157–64. (February 1998). doi:10.1177/002215549804600204. PMID (9446822).
“Protease-activated receptor genes are clustered on 5q13”. Blood92 (1): 25–31. (July 1998). doi:10.1182/blood.V92.1.25.413k41_25_31. PMID (9639495).
“Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase”. Experimental Dermatology8 (4): 282–94. (August 1999). doi:10.1111/j.1600-0625.1999.tb00383.x. PMID (10439226).
“Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates”. The Journal of Biological Chemistry275 (34): 26333–42. (August 2000). doi:10.1074/jbc.M002941200. PMID (10831593).
“Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry”. Biochemistry39 (35): 10812–22. (September 2000). doi:10.1021/bi0003341. PMID (10978167).
“Protease-activated receptors in human airways: upregulation of PAR-2 in respiratory epithelium from patients with asthma”. The Journal of Allergy and Clinical Immunology108 (5): 797–803. (November 2001). doi:10.1067/mai.2001.119025. PMID (11692107).
“Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2”. Journal of Immunology167 (11): 6615–22. (December 2001). doi:10.4049/jimmunol.167.11.6615. PMID (11714832).
“Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells”. Journal of Immunology168 (7): 3577–85. (April 2002). doi:10.4049/jimmunol.168.7.3577. PMID (11907122).
“Protease-activated receptor 2 has pivotal roles in cellular mechanisms involved in experimental periodontitis”. Infection and Immunity78 (2): 629–38. (February 2010). doi:10.1128/IAI.01019-09. PMC 2812191. PMID (19933835). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812191/.
“Protease-Activated Receptors: PAR2”. IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. 2021年4月29日閲覧。